Financhill
Back

Astrana Health 10K Form

Sell
40

ASTH
Astrana Health

Last Price:
42.1200
Seasonality Move:
29.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASTH News And Ratings

See the #1 stock for the next 7 days that we like better than ASTH

ASTH Financial Statistics

Sales & Book Value

Annual Sales: $1.39B
Cash Flow: $31.69M
Price / Cash Flow: 28.78
Annual Sales: $14.75
Price / Book: 2.73

Profitability

EPS (TTM): 1.30000
Net Income (TTM): $62.46M
Gross Margin: $214.96M
Return on Equity: 12.67%
Return on Assets: 5.41%

Astrana Health Earnings Forecast

Key Astrana Health Financial Ratios

  • The Gross Profit Margin over the past 15 years for ASTH is 15.50%.
  • The Selling, General & Administrative Expenses for ASTH have been equal to 8.12% of Gross Profit Margin.
  • The Interest Expense is 26.52% of Operating Income.
  • The Net Earning history of ASTH is 4.38% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 8 years.

Astrana Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ASTH
Website: astranahealth.com

Debt

Debt-to-Equity Ratio: 0.62
Current Ratio: 1.91
Quick Ratio: 1.84

Price-to-Earnings

Trailing P/E Ratio: 32.64
Forward P/E Ratio: 21.06

ASTH Technical Analysis vs Fundamental Analysis

Sell
40
Astrana Health (ASTH) is a Sell

Is Astrana Health a Buy or a Sell?

  • Astrana Health stock is rated a Sell
    The current Astrana Health [ASTH] share price is $42.1100. The Score for ASTH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.